CTLA4 and melanoma: Of specific note, it has been well demonstrated that gut commensal bacteria such as Bifidobacterium and Bacteroidales could significantly improve tumor control of melanoma treated by anti-PD-L1 or anti-CTLA-4 via enhancing antitumor immunity response in mice models (26, 27).